Inseego Reports Second Quarter 2025 Financial Results GlobeNewswire August 07, 2025 Q2 2025 revenue of $40.2 millionQ2 2025 Adjusted EBITDA of $4.7 million and GAAP Net Income of $0.5 millionPaid off $14.9 million balance of 2025 Convertible Notes Entered into a $15.0 million undrawn working capital facility for further operating flexibility and liquidity SAN DIEGO, […]
(NASDAQ:STEP), NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) — StepStone Group Inc. (Nasdaq: STEP), a global private markets investment firm focused on providing customized investment solutions and advisory and data services, today reported results for the quarter ended June 30, 2025. This represents results for the first quarter of the fiscal year ending March 31,
VAALCO Energy, Inc. Declares Third Quarter 2025 Dividend GlobeNewswire August 07, 2025 HOUSTON, Aug. 07, 2025 (GLOBE NEWSWIRE) — Vaalco Energy, Inc. (NYSE: EGY; LSE: EGY) (“Vaalco” or the “Company”) today announced that it declared its quarterly cash dividend of $0.0625 per share of common stock for the third quarter of 2025 ($0.25 annualized), which
Synaptics Reports Fourth Quarter and Full Year Fiscal 2025 Results GlobeNewswire August 07, 2025 Fiscal 2025 revenue grew 12.0%, fueled by 53% growth in Core IoT product sales Synaptics' Board of Directors approved a new share repurchase program of up to $150 million Fiscal 2025 Financial Highlights Revenue of $1.074 billion increased 12% year-over-year Core
Fractyl Health Announces Closing of $23 Million Underwritten Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares GlobeNewswire August 07, 2025 Offering included participation from leading institutional investors, including Nantahala Capital, ADAR1 Capital Management, Second Line Capital, 683 Capital, and SilverArc Capital Proceeds expected to extend cash runway through key upcoming 3-and
Relmada Therapeutics Reports Second Quarter 2025 Financial Results and Announces NDV-01 6-Month Follow-up Safety and Efficacy Data in NMIBC GlobeNewswire August 07, 2025 6-month follow-up for NDV-01 showed a 91% overall response rate at any time in non-muscle invasive bladder cancer, with good overall safety Enrollment in the Phase 2 study for NDV-01 continues, with
Century Aluminum Company Reports Second Quarter 2025 Results GlobeNewswire August 07, 2025 CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) — Century Aluminum Company (NASDAQ: CENX) today announced its second quarter 2025 results. Second Quarter 2025 Financial Results $MM (except shipments and per share data) Q2 2025 Q1 2025 Aluminum shipments (tonnes) 175,741 168,672 Net sales $
Organogenesis Holdings Inc. Reports Second Quarter 2025 Financial Results GlobeNewswire August 07, 2025 CANTON, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported financial
AvePoint Announces Second Quarter 2025 Financial Results GlobeNewswire August 07, 2025 Total quarterly revenue surpassed $100 million for the first timeSecond quarter SaaS revenue of $77.3 million, representing 44% year-over-year growth, 40% on a constant currency basisSecond quarter Total revenue of $102.0 million, representing 31% year-over-year growth, 27% on a constant currency basisTotal ARR of
(NasdaqGM:AVDL), DUBLIN, Aug. 07, 2025 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel's Board of Directors approved the grant of non-statutory options to eight (8) new employees to purchase 60,400 ordinary shares under Avadel's 2021 Inducement Plan. The